Insmed (INSM) Receivables (2010 - 2026)
Insmed (INSM) reported Receivables of $215.33 million for Q2 2026, up 291.3% from $55.03 million a year earlier and up 20.6% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Insmed posted Receivables of $140.86 million, up 170.8% from FY2024.
- Receivables has increased for five consecutive years, with a five-year compound annual growth rate of 53.4% (FY2020 to FY2025).
- By year, Receivables came in at $52.01 million in FY2024 (+26.3%), $41.19 million in FY2023 (+38.6%), $29.71 million in FY2022 (+22.0%) and $24.35 million in FY2021 (+47.0%).
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q4 2010.
- Year over year, Receivables has now increased in each of the last 22 quarters, with growth averaging 112.6% over the last eight quarters.
- The year-over-year growth in Receivables has ranged between 5.0% (Q2 2023) and 291.3% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $178.56 million (Q1 2026), $140.86 million (Q4 2025) and $65.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn | 259.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 259.27 Mn |
| Jun 30, 2026 | 215.33 Mn |
| Mar 31, 2026 | 178.56 Mn |
| Dec 31, 2025 | 140.86 Mn |
| Sep 30, 2025 | 65.26 Mn |
| Jun 30, 2025 | 55.03 Mn |
| Mar 31, 2025 | 47.75 Mn |
| Dec 31, 2024 | 52.01 Mn |
| Sep 30, 2024 | 42.32 Mn |
| Jun 30, 2024 | 40.30 Mn |
| Mar 31, 2024 | 37.16 Mn |
| Dec 31, 2023 | 41.19 Mn |
| Sep 30, 2023 | 35.58 Mn |
| Jun 30, 2023 | 30.95 Mn |
| Mar 31, 2023 | 30.52 Mn |
| Dec 31, 2022 | 29.71 Mn |
| Sep 30, 2022 | 27.40 Mn |
| Jun 30, 2022 | 29.48 Mn |
| Mar 31, 2022 | 25.72 Mn |
| Dec 31, 2021 | 24.35 Mn |
API Access
Insmed Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();